(Total Views: 436)
Posted On: 12/03/2019 1:10:51 PM
Post# of 110

$SNGX News Article - Soligenix Completes Enrollment in its Pivotal Phase 3 Clinical Trial of SGX301 in the Treatment of Cutaneous T-cell Lymphoma https://marketwirenews.com/news-releases/soli...41935.html


My Twitter: WhyteStocks